相关实验视频

Updated: Jul 12, 2026

Using Fluorescent Proteins to Monitor Glycosome Dynamics in the African Trypanosome

Using Fluorescent Proteins to Monitor Glycosome Dynamics in the African Trypanosome

Published on: August 19, 2014

糖向Trypanosoma brucei的感染阶段,具有很高的选择性

Estefanía Dibello¹, Natalia Oddone², Jaime Franco²

¹Laboratory Redox Biology of Trypanosomes, Institut Pasteur de Montevideo, Mataojo 2020, CP 11400, Montevideo, Uruguay; Organic Chemistry Department, Facultad de Química, Universidad de la República, Montevideo, Uruguay.

International journal for parasitology. Drugs and drug resistance

|March 10, 2024

概括

新的含化合物显示出对非洲试体的活性有所改善. 这些新型的基结合物提供了更好的选择性,可能导致更有效的治疗试索症.

科学领域:

药用化学医学化学
寄生虫学的寄生虫学
有机化学有机化学

背景情况:

迪格利科西尔脱化物以前显示对非洲试体的活性,但缺乏选择性.
提高抗试体剂的效力和选择性对于开发新疗法至关重要.

研究的目的:

为了合成和评估新的基合物,以增强抗试体活性和选择性.
研究最有前途的化合物的作用机制.

主要方法:

合成33种新型的基糖结合物,包括基糖化物和甘基基硫化物.
在体外对血流Trypanosoma brucei和小鼠/人类巨细胞进行检测,以确定IC50和选择性指数.
分析化学结构对活性和选择性的影响.
对细胞效应的研究,包括低分子量硫醇 (LMWT) -redox恒温的扰乱.

主要成果:

三种单糖化物和三种糖单硫化物显示出针对Trypanosoma brucei的亚微分子IC50值.
与巨细胞相比,四种化合物具有显著提高的选择性 (选择性指数>38倍).
甘氨基烯硫酸的抗试osomal活性是独立于附加到硫的部分.
最有选择性的化合物迅速扰乱了LMWT-redox平衡,这表明一种潜在的作用机制涉及与自由硫醇一起形成烯硫化物.

结论:

新型的基结合物,特别是基化物和甘基基硫化物,代表了对抗三体药物开发的有希望的线索.
这些化合物提供了更好的功效和选择性,解决了早期disenide衍生物的局限性.
通过醇相互作用扰乱氧化还原稳定是一种可能的机制,有助于它们的抗寄生虫作用.

关键词:

血流中的试虫体巨细胞是一个巨细胞.氧化应激是一种氧化应激.氧化生物传感器生物传感器基糖化物是一种基糖化物.

更多相关视频

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns

Published on: April 6, 2019

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

相关概念视频

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...